Timothy Joseph Murtha, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Retinopathy | 5 | 2013 | 1205 | 0.350 |
Why?
|
| Cataract Extraction | 2 | 2017 | 482 | 0.320 |
Why?
|
| Vitrectomy | 2 | 2007 | 365 | 0.280 |
Why?
|
| Eye Infections, Fungal | 1 | 2004 | 110 | 0.210 |
Why?
|
| Retinal Vein Occlusion | 1 | 2004 | 137 | 0.210 |
Why?
|
| Candidiasis | 1 | 2004 | 365 | 0.190 |
Why?
|
| Endophthalmitis | 1 | 2004 | 263 | 0.190 |
Why?
|
| Candida albicans | 1 | 2004 | 394 | 0.190 |
Why?
|
| Optic Nerve Diseases | 1 | 2003 | 327 | 0.170 |
Why?
|
| Cataract | 3 | 2017 | 833 | 0.160 |
Why?
|
| Retinal Diseases | 2 | 2003 | 683 | 0.160 |
Why?
|
| Visual Pathways | 1 | 2003 | 565 | 0.160 |
Why?
|
| Macular Edema | 2 | 2013 | 359 | 0.140 |
Why?
|
| Vision Disorders | 1 | 2003 | 1057 | 0.130 |
Why?
|
| Vision, Low | 1 | 2017 | 168 | 0.130 |
Why?
|
| Retina | 3 | 2012 | 2611 | 0.120 |
Why?
|
| Visual Acuity | 7 | 2017 | 2520 | 0.100 |
Why?
|
| Phacoemulsification | 1 | 2013 | 149 | 0.100 |
Why?
|
| Triamcinolone Acetonide | 1 | 2011 | 101 | 0.090 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2012 | 246 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 4 | 2013 | 2637 | 0.080 |
Why?
|
| Porphyrins | 1 | 2011 | 348 | 0.080 |
Why?
|
| Photography | 1 | 2012 | 521 | 0.080 |
Why?
|
| Disease Management | 1 | 2017 | 2450 | 0.070 |
Why?
|
| Photochemotherapy | 1 | 2011 | 804 | 0.060 |
Why?
|
| Amphotericin B | 1 | 2004 | 137 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2011 | 980 | 0.060 |
Why?
|
| Color Vision Defects | 1 | 2003 | 28 | 0.060 |
Why?
|
| Optical Illusions | 1 | 2003 | 40 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2004 | 356 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2017 | 11695 | 0.050 |
Why?
|
| Granuloma | 1 | 2004 | 315 | 0.050 |
Why?
|
| Perceptual Disorders | 1 | 2003 | 196 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2013 | 3336 | 0.050 |
Why?
|
| Hallucinations | 1 | 2003 | 360 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7276 | 0.050 |
Why?
|
| Motion Perception | 1 | 2003 | 408 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2004 | 729 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 8621 | 0.040 |
Why?
|
| Visual Fields | 1 | 2003 | 1049 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 2623 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9274 | 0.030 |
Why?
|
| Sunlight | 1 | 1994 | 325 | 0.030 |
Why?
|
| Depth Perception | 1 | 2012 | 94 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15244 | 0.020 |
Why?
|
| Intravitreal Injections | 1 | 2011 | 345 | 0.020 |
Why?
|
| Retreatment | 1 | 2011 | 604 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2013 | 936 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 1994 | 859 | 0.020 |
Why?
|
| Photosensitizing Agents | 1 | 2011 | 602 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 2593 | 0.020 |
Why?
|
| Humans | 10 | 2017 | 742088 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2012 | 1538 | 0.020 |
Why?
|
| Anthropometry | 1 | 2006 | 1350 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2011 | 2107 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13256 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 2038 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 6483 | 0.010 |
Why?
|
| Reference Values | 1 | 2008 | 4982 | 0.010 |
Why?
|
| Adult | 4 | 2013 | 213712 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3502 | 0.010 |
Why?
|
| Insulin | 1 | 1994 | 6575 | 0.010 |
Why?
|
| Male | 5 | 2013 | 349538 | 0.010 |
Why?
|
| Perfusion | 1 | 1982 | 1359 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14720 | 0.010 |
Why?
|
| Middle Aged | 4 | 2013 | 213127 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 20928 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15530 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 19862 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 1994 | 472 | 0.010 |
Why?
|
| Female | 5 | 2013 | 379592 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 162944 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39004 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 53187 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57683 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 72145 | 0.000 |
Why?
|
| Time Factors | 1 | 2006 | 40054 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2011 | 62966 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2011 | 77098 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1982 | 381 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1982 | 2191 | 0.000 |
Why?
|
| Capillaries | 1 | 1982 | 774 | 0.000 |
Why?
|
| Biometry | 1 | 1982 | 558 | 0.000 |
Why?
|
| Brain | 1 | 1982 | 26343 | 0.000 |
Why?
|
| Body Weight | 1 | 1982 | 4664 | 0.000 |
Why?
|
| Heart Rate | 1 | 1982 | 4091 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1982 | 8541 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1982 | 5705 | 0.000 |
Why?
|
| Rats | 1 | 1982 | 24265 | 0.000 |
Why?
|
| Animals | 1 | 1982 | 168561 | 0.000 |
Why?
|